Clinical trial

PANORAMA - Real World Molecular Testing, Treatment Patterns, and Clinical Outcomes EGFR Mutation-Positive NSCLC

NCT02777658

StatusCOMPLETED

Study typeOBSERVATIONAL

Start date2016-05-26

PhaseN/A

Study timeline

Study start (actual)2016-05-26Date precision: day

Registry last updated2021-05-27

Observed by CureCurrent2026-10-07

Recorded dates are source observations, not predictions. Missing milestones are not estimated.

Conditions

Carcinoma, Non-Small-Cell Lungunresolved

Interventions

Sponsors & collaborators

AstraZenecalead sponsor

iOMEDICO AG, Freiburg, Germanycollaborator

Mapped research locations

BerlinGermany1 HamburgGermany1 MünchenGermany1 DresdenGermany1 LeipzigGermany1 HanoverGermany1 CologneGermany1 MainzGermany1 DüsseldorfGermany1 BonnGermany1 BochumGermany1 WürzburgGermany1

Registry source

Open the source record to verify current eligibility, contacts, locations and registry updates.

Open NCT02777658 on ClinicalTrials.gov ↗

Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.